Primary ovarian insufficiency (POI) is a serious reproductive dysfunction in which the follicle pool is reduced and depleted.
INTRODUCTION
Primary ovarian insufficiency (POI), previously known as premature ovarian failure, refers to a disorder of infertility characterized by amenorrhea or menstrual irregularity and elevated levels of follicle-stimulating hormone (FSH) before 40 years of age [1] . The development of POI may result from an initial decrease of the primordial follicle pool or acceleration of follicular atresia [2] , but the precise mechanism is unknown. Apoptosis of granulosa cells (GCs) is conventionally believed to be the cellular mechanism of ovarian follicular atresia [3, 4] . Some studies also have demonstrated that apoptosis of ovarian GCs could result in follicle loss [5] [6] [7] .
As the primary cell type in the follicle, GCs provide the physical support and microenvironment required for the developing oocyte. Survival of the GCs following ovulation and their luteinization is critical to the ability to sustain pregnancy [8] and to biosynthesize two important ovarian steroids, estradiol (E2) and progesterone (P4) [9, 10] .
Some studies have shown that P4 receptor membrane component 1 (PGRMC1) not only regulates cell viability [11] and sexual steroid hormones biosynthesis [12, 13] , but it also mediates the antiapoptotic effects of P4 on GCs [11, 14, 15] . Moreover, PGRMC1 can prevent cells from apoptosis and maintain survival of GCs in the absence of P4 [16] . Clinical data show that PGRMC1 expression is obviously downregulated in both postmenopausal women and POI patients [17] . However, little is known about how PGRMC1 expression is regulated.
Hyaluronic acid (HA), an important matrix molecule, is recognized as the functional ligand involved in the control of dynamic biological functions such as cell migration, proliferation, and differentiation [18] . Previous studies have shown that GCs can produce HA and HA can inhibit the apoptosis of GCs [6, [19] [20] [21] . The level of HA in follicular fluids is thought to be an indicator of the estimation of oocyte viability for fertilization [22] . In addition, it is demonstrated that cumulus expansion is the result of HA synthesis and accumulation, leading to oocyte maturation [23] . It was found that CD44 is a major HA receptor in human and mouse cells [24, 25] . Sufficient interaction between HA and CD44 during cumulus expansion is crucial for oocyte maturation [26] . Recent studies show that HA/CD44-mediated nuclear translocation of transcription factors plays an important role in regulating target gene expression and cell activation [27] . However, it is unclear whether there is interaction of HA and PGRMC1 expression in modulating the proliferation and function of GCs and in the pathogenesis of POI.
To study whether PGRMC1 was regulated by HA in GCs, we detected levels of mRNA and PGRMC1 protein in GC tumor cell line and rat primary GCs after treatment with HA. Furthermore, we investigated the regulation mechanism by HA on PGRMC1expression. We found that HA up-regulated PGRMC1 expression in GCs via suppression of miR-139-5p and that HA inhibited miR-139-5p via histone deacetylation of its promoter. Taken together, we report a new mechanism for HA regulation of PGRMC1 expression, suggesting HA may be a potential molecule for prevention and treatment of POI.
MATERIALS AND METHODS

Study Subjects with POI
A total of 52 patients with idiopathic POI were recruited in the present investigation. The demography and general clinical characteristics are listed in Table 1 . Thirty healthy cycling women of comparable ages were included to serve as controls. Informed consent was obtained from each patient and control woman. Blood samples were collected from the patients in ethylenediaminetetraacetic acid (EDTA)-containing tubes before the start of treatment. The study protocol was approved by the institutional ethics committee of Nanjing Drum Tower Hospital.
Culture of Granulosa Tumor Cells and Rat Primary Granulosa Cells
The KGN cell line (a generous gift from Dr. Yiming Mu at the General Hospital of the People's Liberation Army, Beijing, China), derived from human ovarian granulosa cell tumor that expresses typical GC markers, was cultured in DF-12 medium containing 10% fetal bovine serum (FBS) and 50 mg/ml penicillin and streptomycin. Rat primary GCs were isolated from female Sprague-Dawley rats as previously described [28] . Briefly, Sprague-Dawley rats were injected subcutaneously with 40 IU of pregnant mare's serum gonadotropin (Folligon; Intervet) at 28 days of age to stimulate the development of preantral follicles. After 48 h, GCs were released by puncturing follicles. Cells were pelleted at 100 3 g for 15 min, counted using trypan blue, and plated at a density of approximately 1 3 l0 6 cells/ml on plastic dishes (Falcon, BD Biosciences) coated with 0.5 mg/ml human plasma fibronectin (Sigma) in Dulbecco modified Eagle medium/Ham F-12 medium (1:1) with 15 mM HEPES, 3.15 g/L glucose containing 10% FBS, and 50 mg/ ml penicillin and streptomycin. All animal experiments were performed according to the guidelines of the Experimental Animals Management Committee (Jiangsu Province, China).
RNA Isolation and Quantitative Real-Time PCR
The EDTA anticoagulated blood samples were subjected to isolation of peripheral blood mononuclear cells (PBMCs) by Ficoll gradient centrifugation. Total RNA from the PBMCs or cultured cells was extracted by TRIzol reagent (Invitrogen) and stored at À808C. RNA (1 lg) was reverse-transcribed using Revert Aid first-strand cDNA synthesis kit (Fermentas). miR-139-5p, U6, PGRMC1, cyclin D2 (CCND2), p450scc, CYP19a, and GAPDH levels were measured, each performed in triplicate with 3 to 6 separate experiments, using a real-time PCR kit (Roche) with an ABI 7500 Fast unit (Applied Biosystems). miR-139-5p was normalized using U6, and the results of other molecules were normalized using b-actin. The comparative cycle threshold method was used to quantitatively analyze the results. Data are presented as relative to expression in control cells.
Western Blot Analysis
Whole cells were added with 200 ll of buffer containing 50 mM Tris-Cl, pH 8.0, 150 mM NaCl, 0.1% SDS, 100 lg/ml phenylmethylsulfonyl fluoride, 1 lg/ml aprotinin, 1% Triton, and 0.02% NaN 3 . Protein concentrations were determined using BCA protein assay (Bio-Rad Laboratories). The cellular proteins (100 lg) were subjected to 12% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore). Membranes were blocked for 1 h in TBST (10 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.05% Tween-20) containing 2% nonfat dried milk. Then, PGRMC1 rabbit antibody (catalog no. 12990-1-AP; ProteinTech Group, Inc.) and GAPDH antibody (Sigma), respectively, were used to probe the corresponding proteins on the membranes, followed by addition of horseradish peroxidase-labeled secondary antibodies. Protein bands were detected by enhanced chemiluminescence reaction (Millipore). As a negative control, either the primary antibody was omitted or a rabbit IgG was used in place of the PGRMC1 antibody.
ELISA
Levels of HA in sera from 52 POI patients and 30 healthy cycling women were measured using an ELISA kit (biotin-linked antibody to hyaluronanbinding protein; Merck Chemicals). The culture supernatants of KGN and primary GCs were collected separately at 48 h after treatment with HA or after miRNA transfection. Then, E2 and P4 levels were measured using cradioimmunoassay with a GC-1200 c-radioimmunoassay counter according to the manufacturer's instructions (Tianjin Nine Tripods Medical and Bioengineering Co., Ltd.).
Annexin V/Propidium Iodide Staining
After KGN cells were transfection with miR-139-5p-related sequences for 48 h, they were collected by centrifugation, washed once with binding buffer (10 mM Hepes, 140 mM NaCl and 2.5 mM CaCl 2 ), and stained with 5 ll of annexin V-fluorescein isothiocyanate (FITC) at room temperature for 15 min. Cells were stained with propidium iodide (PI) and then analyzed by flow cytometry. Both PI and annexin V-negative cells were judged to be viable cells, and annexin V-positive and PI-negative cells were apoptotic cells, whereas both annexin V and PI-labeled cells were late apoptotic dead cells. Nonviable cells that underwent necrosis were positive for PI and negative for annexin V.
Constructs for Luciferase Reporter
To determine the target relationship of miR-139-5p and PGRMC1, we amplified the PGRMC1 3 0 -untranslated region (UTR) fragment from human genomic DNA with PCR using the forward primer 5 0 -GCTCTAGAAGCATT CAGTGGAAGTATATCTA-3 0 and the reverse primer 5 0 -GCTCTAGATA CAGAACATCATGACTAAAAGTT-3 0 . The resultant PCR products were purified and cloned into the pGL3-control-luciferase vector (Promega). Inserts in the plasmids were confirmed by DNA sequencing.
Luciferase Assays
KGN and primary cells were plated separately in 24-well plates at a density of ;1.5 3 10 4 cells per well, and 250 ng of pGL3-luciferase reporter and 5 ng of Renilla luciferase reporter were added to each well. Cells were then harvested using lysis buffer (Promega) after the indicated treatment. Luciferase and Renilla luciferase activities were determined using dual luciferase assay (Promega) in a plate Chameleon luminometer (BioScan). Firefly luciferase was normalized by Renilla luciferase to correct for transfection efficiency. Fold induction was determined by dividing the averaged normalized values from each treatment by the control value for each transfection condition within that experiment. Values were averaged from multiple experiments as indicated in the figure legend.
Flow Cytometry
Expression of CD44 in the KGN cells was detected using flow cytometry after the KGN cells were treated with 200 lg/ml HA for 48 h. The CD44 murine monoclonal antibody (BD Biosciences) conjugated with FITC and immunoglobulin G (IgG)/IgM isotype controls (BD Biosciences) were used in fluorescence-activated cell sorting (FACS) analysis. For fluorescence measure- ZHAO ET AL.
ments, 10 000 single cell events were collected using a standard FACScalibur flow cytometer (BD Biosciences). Mean fluorescence intensity (MFI) was analyzed using CELLQuest (BD Biosciences).
Statistics
Statistical analyses were performed using Prism version 5.01 software (GraphPad). Data are means 6 SEM for the number of independent experiments indicated in each figure legend. Analysis with one-way ANOVA followed by Student-Newman-Keuls multiple comparisons tests were used for the comparison of three or more experimental groups. For comparison of two experimental groups, Student t test was used when the data were normally distributed. When the data were not normally distributed, nonparametric test was applied. Statistical significance was defined as a P value of ,0.05. Analysis of the correlation of HA or miR-139 with PGRMC1 expression in POI patients was conducted by bivariate (Spearman correlation) analysis.
RESULTS
PGRMC1 Expression Is Correlated with Serum HA Level in POI Patients
We used ELISA to test levels of HA in sera samples from 52 POI patients and 30 healthy cycling women and measured PGRMC1 mRNA levels in PBMCs of these subjects. Results showed that the average HA level in POI patients was 41.14 ng/L, significantly lower than that in healthy women (84.77 ng/ L) (Fig. 1A) . The mRNA level of PGRMC1 was also downregulated in PBMCs from the POI patients compared with that of normal women (Fig. 1B) .
Because POI patients showed reduced sera HA levels and PGRMC1 mRNA levels in PBMCs, we speculated whether the serum HA level was correlated with PGRMC1 level in PBMCs. As shown in Figure 1C , there was a significant correlation between HA and PGRMC1 in the POI patients (R 2 ¼ 0.5215, P , 0.01).
HA Induces Expression of PGRMC1 in KGN cells
Because of the correlation of HA with PGRMC1 observed in the patients (Fig. 1C) and the fact that PGRMC1 reportedly plays an important role in the proliferation and function of GCs, we determined whether PGRMC1 was a target gene of HA. We cultured KGN cells in the presence of HA (chemical abstracts no. 9004-61-9; Worthington Biochemical Corp.) and then quantitatively measured the PGRMC1 mRNA levels by quantitative RT-PCR (qRT-PCR) and the PGRMC1 protein levels by Western blotting. PGRMC1 mRNA levels showed a 1.7-fold increase at 12 h and a 2.0-fold increase at 24 h in the KGN cells in the presence of HA (Fig. 2A) . Dose-response experiments revealed maximal PGRMC1 mRNA induction with 200 lg/ml HA after 12 h of treatment in the KGN cells (Fig. 2B) . Furthermore, the PGRMC1 protein level was assessed after treatment with 200 lg/ml HA for 24 h and 48 h in the KGN cells. The results showed that PGRMC1 protein levels were also significantly up-regulated in HA-treated cells (Fig. 2, C and D) . Specificity validation analysis revealed that PGRMC1 antibody can detect the ;27-kDa form of PGRMC1 in KGN cells (Fig. 2C, left panel) .
To investigate the mechanisms responsible for the induced expression of PGRMC1 by HA, we performed luciferase reporter assay experiments to determine whether HA might bind with the promoter of PGRMC1. We constructed PGRMC1 promoter luciferase reporter plasmid and transfected the plasmid into KGN cells. After the cells were treated with 200 lg/ml HA for 24 h, the luciferase activity in the cells was comparable to that in the cells without HA treatment (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org), Thus, HA had no effect on PGRMC1 promoter activity, indicating that HA induced PGRMC1 expression in a different way.
miR-139-5p Is Involved in HA-Induced Expression of PGRMC1
It has been reported that HA may affect gene expression through regulation of the expression of miRNAs [29, 30] . Therefore, we supposed that miRNAs might be involved in HA-induced expression of PGRMC1. According to previous reports [31, 32] , we used miRNA gene network analysis system and other target prediction programs [33] [34] [35] to select several miRNAs that might target PGRMC1. We found that miR-139-5p, miR-98, miR-7, and miR-7i might target PGRMC1. Indeed, 3 of the 4 above-described miRNAs, miR-98, miR-7, and miR-7i, were reported to target PGRMC1 [36] [37] [38] . Thus, we focused on the possible roles of miR-139-5p, miR-98, miR-7, and miR-7i on HA-induced expression of PGRMC1. Real-time PCR analysis showed that miR139-5p, miR-7g, miR-7i, and miR-98 were up-regulated in PBMCs from POI patients (Fig. 3A) . Of the three, miR139-5p was increased most significantly (Fig. 3A) . Furthermore, we found that mRNA level of PGRMC1 in PBMCs from the patients was also negatively correlated with the level of miR-139-5p (r ¼ À0.7634, P , 0.0001) (Fig. 3B) .
To demonstrate whether the expression of these miRNAs in GCs was regulated by HA, the KGN cells were treated with 200 lg/ml HA, and then the expression of miRNAs was analyzed. As shown in Figure 3C , miR-139-5p expression was reduced by 45% at 6 h and by 60% at 12 h in the presence of HA, whereas the levels of miR-7g, miR-7i, and miR-98 were not changed significantly. These results indicated that miR-139-5p might be a candidate miRNA in the up-regulation of HA on PGRMC1 expression. 
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To verify whether miR-139-5p targets PGRMC1, the expression of PGRMC1 in the KGN cells was detected after the cells were separately transfected with a miR-139-5p mimic and its inhibitor. miRNA inhibitors are synthetic antisense oligonucleotides, which are complementary to mature miRNA sequences, used for loss-of-function studies of miRNAs. The results showed that the expression of PGRMC1 in KGN cells was down-regulated after the cells were treated with the miR-139-5p mimics, whereas its expression was up-regulated after the cells were treated with the miR-139-5p inhibitor (Fig. 3D) .
Luciferase reporter assay demonstrated that miR-139-5p significantly suppressed the expression of a luciferase reporter gene fused to 3 0 -UTR of PGRMC1, which could be reversed by further introduction of miR-139-5p inhibitor in the KGN cells and rat GCs (Fig. 3E and Supplemental Fig. S2C ). Deletion of miR-139-5p attenuated the promotive effect of HA on the expression of PGRMC1 (Fig. 3F) . 0 UTR constructs and miR-139-5p or its inhibitor for 24 h. F) Before HA treatment, KGN cells were transfected with miR-139-5p inhibitor or its negative control for 24 h. Expression of PGRMC1 was assessed by real-time PCR. Results are the average of three independent experiments conducted on different days. *P , 0.05, **P , 0.01 versus control. Nonsignificant (ns), P . 0.05.
HA PROMOTES PGRMC1 EXPRESSION IN GCS
miR-139-5p Affects Apoptosis and Function of GCs
To investigate the role of miR-139-5p in the proliferation and function of GCs, the miR-139-5p mimic and miR-139-5p inhibitor were transfected into the KGN cells. The results showed that the density of miR-139-5p-transfected KGN cells after 48 h was lower than that of miR-139-5p negative control sequence-transfected cells (Fig. 4A) . Apoptosis analysis showed that apoptosis of the KGN cells increased to nearly 20% in the presence of miR-139-5p at 48 h, whereas apoptosis was reduced in the cells treated with the miR-139-5p inhibitor (Fig. 4, B and C) . Moreover, expression of CCND2, a marker of cell proliferation, was down-regulated after transfection with the miR-139 mimics for 24 h compared with that in miR-139 inhibitor-transfected cells (Fig. 4D) . We also found that the levels of CYP19A (an E2 synthesis enzyme) and p450scc (a P4 synthesis enzyme) were significantly decreased in the presence of miR-139 (Fig. 4D) .
Because miR-139-5p inhibited the mRNA levels of CYP19A and p450scc, we further investigated whether the secretion of E2 and P4 in GCs was reduced by miR-139-5p. Noticeably, KGN cells cannot secrete E2 [10] . Therefore, we measured the concentrations of E2 and P4 in rat primary GCs. Using miRNA gene network analysis, we found that both the sequence and target motifs of miR-139-5p were the same in rat and human (Supplemental Fig. S2A ). The level of miR-139-5p was also downregulated in rat GCs in the presence of HA (Supplemental Fig. S2B ). Consistent with these findings, the concentration of E2 decreased from 100 pg/ml to 60 pg/ml and that of P4 decreased from 2500 pg/ml to 1500 pg/ml, respectively, in rat primary GCs transfected with rat miR-139-5p mimics and miR-139-5p inhibitor (Fig. 4E) .
HA Suppresses miR-139-5p Expression via Histone Deacetylation in Its Promoter Region
To investigate the mechanism of HA in regulation of miR-139-5p expression, we first detected the expression of CD44, a major HA receptor [24, 25] , in HA-treated KGN cells by flow cytometry. Results showed that MFI of CD44 expression in the HA-treated cells was increased from 7.8 to 15.2 (P , 0.01) (Fig. 5A) . Then we transfected KGN cells with CD44-specific siRNAs (siCD44), followed by treating the cells with HA, and then we detected the level of miR-139-5p by using qRT-PCR. The results showed that miR-139-5p expression in the KGN cells was 1.5-fold increased after siCD44 treatment (P , 0.05), whereas the inhibitory effects of HA on miR-139-5p expression was attenuated after pretreatment with siCD44 ZHAO ET AL. (Fig. 5B) . Furthermore, we constructed the luciferase reporter plasmid containing miR-139 promoter region (À1500 to 200 bp) as reported previously [39] . The KGN cells were transfected with constructed plasmid for 24 h and treated again with HA for 12 h, and then the luciferase activity was assessed. Surprisingly, results showed that HA had no effect on miR-139 expression from the plasmid (Fig. 5C) .
Of note, epigenetic modification is a way to regulate miR-139 expression in gastric cancer cells [39] . Using bisulfite genomic sequencing, we found that the methylation levels of the miR-139 promoter in the HA-treated cells were the same as those in untreated cells (Supplemental Fig. S3 ). Real-time PCR analysis revealed that miR-139-5p was up-regulated by treatment with the histone deacetylase inhibitor trichostatin A (TSA; Sigma) in the KGN cells (Fig. 5D) . Expression of miR-139-5p was even increased up to 7 times in the cells after cotreatment with siCD44 and TSA, compared with that in the nontreated cells (Fig. 5D) . Meanwhile, PGRMC1 mRNA and protein levels were significantly down-regulated by TSA treatment (Fig. 5, E and F) .
Furthermore, we measured the levels of E2 and P4 in rat GCs after treatment with HA alone or with both HA and TSA. Results showed that HA alone increased the concentration of E2 from 75 pg/ml to 130 pg/ml (P , 0.01) and P4 from 1500 pg/ml to 2700 pg/ml (P , 0.01), respectively. In contrast, E2 and P4 levels were decreased to 53 pg/ml (P , 0.01) and 870 pg/ml (P , 0.01), respectively, after treatment with both HA and TSA (Fig. 5G) . Thus, we concluded that down-regulation of miR-139 expression by HA cooperatively with CD44 may be partly attributed to histone deacetylation in the miR-139 promoter region.
DISCUSSION
POI develops because of an initial decrease of the primordial follicle pool or an acceleration of follicular atresia [2] . Apoptosis of GCs is usually believed to be the cellular mechanism of ovarian follicular atresia [3, 4] . Some studies also have demonstrated that abnormal apoptosis of ovarian GCs could result in follicle loss [5] [6] [7] . Therefore, apoptotic inhibition and proliferative promotion of GCs should be an important strategy for the prevention and treatment of POI. Both HA and PGRMC1 are important for proliferation of GCs. It was reported that HA inhibits cell apoptosis [40] , possibly through an interaction with PAIRBP1 (an HA-binding protein), which interacts with PGRMC1 [41, 42] . It indicates that PGRMC1 may correlate with HA. Here we showed that HA promotes the expression of PGRMC1 through regulation of miR-139-5p in GCs and that miR-139-5p promotes the apoptosis of GCs and inhibits the function of GCs. However, the concentration of HA we used in this study was 200 lg/ml, which was approximately 1000-fold higher than that in serum. The high dose of HA used in the in vitro studies are superphysiological, so the affects observed may be pharmacological but may not be physiologically relevant.
PGRMC1 localizes to plasma membrane, cytoplasm, and nucleus in follicle GCs [43] . PGRMC1 also participates in P4 signaling transduction in the reproductive system and mediates the antiapoptotic effects of P4 on GCs [11, 14, 15] . Furthermore, it has been reported that PGRMC1 regulates cell viability through increasing protein kinase G activity and suppressing Erk1/2 activity, as well as by decreasing intracellular free calcium levels [11] , and acts as a positive regulator of several cytochrome P450 (CYP)-catalyzed reactions [44, 45] , which are critical for biosynthesis of sexual steroid hormones [12, 13] . It was reported that PGRMC1 was obviously down-regulated in both postmenopausal women and POI patients [15] . In the present study, we found that the expression of PGRMC1 was associated with HA level in POI patients and that HA promoted the expression of PGRMC1 in KGN cells. It indicates that PGRMC1 is a target gene of HA.
The fact that PGRMC1 expression is down-regulated in PBMCs from POI patients indicates the relationship of PBMCs with ovarian GCs. Emi et al. [46] found that peripheral blood lymphocytes stimulated human granulosa luteal cells to produce progesterone through the action of some protein-like humoral factor(s) of higher molecular weight and indicated a possible paracrinologic regulatory role for lymphocytes in ovarian function. Moreover, Macciò et al. [47] also found that a migration of lymphomonocytes from the peripheral compartment to the follicle occurs during preovulation and that these lymphomonocytes regulated the steroidogenesis of GCs. Therefore, altered PGRMC1 expression in PBMCs may reflect an altered immune state associated with the disease, and this alteration may in turn affect the function of GCs.
HA promotes the expression of PGRMC1 via suppression of miR-139-5p. miRNAs are integral elements in the posttranscriptional control of gene expression. They serve as nodes of signaling networks that ensure homeostasis and regulate cancer, metastasis, fibrosis, and stem cell biology [48] . miRNAs also play an important role in ovary development. Sirotkin et al. [31, 32] identified many miRNAs that could affect proliferation and hormone synthesis in GCs. Here we described the fact that miR-139-5p was inhibited by HA, which consequently relieved the suppression of PGRMC1 in GCs. We also detected miR-7g, miR-7i, and miR-98, all of which target PGRMC1 as reported previously [36] [37] [38] . However, our results showed that these miRNAs could not be involved in HA regulation of PGRMC1. We analyzed the roles of miR-139-5p in proliferation and hormone synthesis in GCs. We found that miR-139-5p inhibits the expression of P450scc and CYP19A, which are key enzymes in E2 and P4 synthesis. We further demonstrated that the E2 and P4 levels were also inhibited by miR-139-5p. These findings are consistent with the reports that PGRMC1 acts as a positive regulator of several cytochrome P450 (CYP)-catalyzed reactions [44, 45] .
CD44 is a major HA receptor [24, 25] . Studies have suggested the importance of HA/CD44-mediated nuclear translocation of transcription factors in regulating target gene expression and cell activation [27] . We found that miR-139-5p was decreased in the KGN cells after treatment with HA (Fig.  5B) . However, when CD44 was silenced, the level of miR-139-5p was not affected by HA (Fig. 5B) . These results indicate that CD44 mediates HA-reduced miR-139-5p. Data are accumulating to support the fact that epigenetic modification of miRNA genes plays an important role in the expression of these regulatory RNAs [49] . In addition, it is reported that histone H3 phosphorylation and acetylation regulate gene expression in ovarian GCs [50] and that HA can affect gene expression through regulating histone deacetylase 3 expression [51] . Our finding that HA up-regulates the expression of PGRMC1 in GCs by down-regulating the miR-139-5p provides novel insight into understanding the complicated regulatory network of proliferation.
In conclusion, we clarified the fact that HA induced the expression of PGRMC1 in GCs via epigenetic silencing of miR-139-5p. These findings shed light on the mechanisms underlying promotion of HA on the expression of PGRMC1 and thus have significant implications for the potential applicability of HA in the treatment of POI.
